Effectiveness and safety of bictegravir/emtricitabine/tenofovir alafenamide fixed dose combination for the treatment of people living with HIV in Argentina: first interim report of the BICTARG cohort
Cecchini et al.

  This content is only accessible to healthcare professionals in Belgium.   To view our restricted content please register HERE. You will be granted immediate access. If you are already registered, please sign-in HERE. To register as a Gilead employee,...

Efficacy and Safety of Switching Older Adults (≥60 Years) from First-Line ART to B/F/TAF in Kenya
A Randomized Clinical Trial (the B/F/TAF Elderly Study)
Ombajo et al.

  This content is only accessible to healthcare professionals in Belgium.   To view our restricted content please register HERE. You will be granted immediate access. If you are already registered, please sign-in HERE. To register as a Gilead employee,...

Week-96 Results of ALLIANCE, a Phase 3, Randomized, Double-Blind Study Comparing B/F/TAF Versus DTG + F/TDF in Treatment-Naïve People With Both HIV-1 and Hepatitis B

  This content is only accessible to healthcare professionals in Belgium.   To view our restricted content please register HERE. You will be granted immediate access. If you are already registered, please sign-in HERE. To register as a Gilead employee,...

Weight Change and Metabolic Assessment of Virologically Suppressed Children With HIV Aged≥ 2 Years and Weighing 14 to < 25 Kg Who Received a TAF-Containing Regimen

  This content is only accessible to healthcare professionals in Belgium.   To view our restricted content please register HERE. You will be granted immediate access. If you are already registered, please sign-in HERE. To register as a Gilead employee,...

Pharmacokinetics (PK), Safety and Efficacy of Bictegravir/Emtricitabine/Tenofovir Alafenamide (B/F/TAF)in Virologically Suppressed Pregnant Women With HIV

  This content is only accessible to healthcare professionals in Belgium.   To view our restricted content please register HERE. You will be granted immediate access. If you are already registered, please sign-in HERE. To register as a Gilead employee,...

IAS 2023

  This content is only accessible to healthcare professionals in Belgium.   To view our restricted content please register HERE. You will be granted immediate access. If you are already registered, please sign-in HERE. To register as a Gilead employee,...

Predictors of Hepatitis B Treatment Response in People with HIV-1/HBV coinfection Avihingsanon et al

  This content is only accessible to healthcare professionals in Belgium.   To view our restricted content please register HERE. You will be granted immediate access. If you are already registered, please sign-in HERE. To register as a Gilead employee,...

Week 52 Subgroup Efficacy of Lenacapavir in Heavily Treatment-Experienced PLWH Ogbuagu et al

  This content is only accessible to healthcare professionals in Belgium.   To view our restricted content please register HERE. You will be granted immediate access. If you are already registered, please sign-in HERE. To register as a Gilead employee,...

CROI 2023

  This content is only accessible to healthcare professionals in Belgium.   To view our restricted content please register HERE. You will be granted immediate access. If you are already registered, please sign-in HERE. To register as a Gilead employee,...

A retrospective, multicenter study on the efficacy, durability, and tolerability of bictegravir/emtricitabine/tenofovir alafenamide (Biktarvy^®) for the treatment of HIV in a real-world setting in Belgium Nasreddine et al.

  This content is only accessible to healthcare professionals in Belgium.   To view our restricted content please register HERE. You will be granted immediate access. If you are already registered, please sign-in HERE. To register as a Gilead employee,...

Outcomes After Switching From 144 Weeks of Blinded DTG/ABC/3TC or DTG + FTC/TAF to 96 Weeks of Open-label Biktarvy^® Orkin et al.

  This content is only accessible to healthcare professionals in Belgium.   To view our restricted content please register HERE. You will be granted immediate access. If you are already registered, please sign-in HERE. To register as a Gilead employee,...

HIV Glasgow 2022

  This content is only accessible to healthcare professionals in Belgium.   To view our restricted content please register HERE. You will be granted immediate access. If you are already registered, please sign-in HERE. To register as a Gilead employee,...